PharmaShots | Incisive News in 3 Shots

Subscribe Now

RRMS

Immunic's IMU-838 Receives the US FDA's IND Approval to Initiate P-III ENSURE & P-II CALLIPER Studies for RRMS & PMS

Immunic's IMU-838 Receives the US FDA's IND Approval to Initiate P-III ENSURE & P-II CALLIPER Studies for RRMS & PMS

July 6, 2021

EMD Serono's Mavenclad (Cladribine) Receives FDA's Approval for RRMS and SPMS in Adults

EMD Serono's Mavenclad (Cladribine) Receives FDA's Approval for RRMS and SPMS in Adults

March 29, 2019

Novartis' Gilenya (fingolimod) Receives EU's Approval for Relapsing-Remitting Forms of Multiple Sclerosis (RRMS)

Novartis' Gilenya (fingolimod) Receives EU's Approval for Relapsing-Remitting Forms of Multiple Sclerosis (RRMS)

November 30, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us